- Home
- CPBI vs ZTEK Comparison
CPBI vs ZTEK Comparison
Compare CPBI & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CPBI | ZTEK |
|---|---|---|
| Founded | 2023 | 2008 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 71.3M | 78.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CPBI | ZTEK |
|---|---|---|
| Price | $17.01 | $0.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.4K | ★ 45.3K |
| Earning Date | 02-10-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.32 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $19,961,000.00 | $657,134.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.63 | ★ N/A |
| Revenue Growth | 9.30 | ★ 2225.73 |
| 52 Week Low | $13.00 | $0.62 |
| 52 Week High | $17.14 | $1.84 |
Technical Indicators
Market Signals| Indicator | CPBI | ZTEK |
|---|---|---|
| Relative Strength Index (RSI) | 63.30 | 59.64 |
| Support Level | $16.80 | $0.64 |
| Resistance Level | $17.03 | $0.75 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 74.17 | 76.77 |
Price Performance
Historical ComparisonAbout CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.